hit policy committee: meaningful use workgroup stage 3 – preliminary recommendations debrief paul...

45
HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co-Chair August 1, 2012 Washington Marriott, 1221 22nd Street, NW, DC 20037

Upload: christian-johnson

Post on 25-Dec-2015

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations

Debrief

Paul Tang, Palo Alto Medical Foundation, ChairGeorge Hripcsak, Columbia University, Co-Chair

August 1, 2012

Washington Marriott, 1221 22nd Street, NW, DC 20037

Page 2: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 2

Workgroup Membership

Co-Chairs:Paul Tang Palo Alto Medical FoundationGeorge Hripcsak Columbia University

Members:• David Bates Brigham & Women’s Hospital• Michael Barr American College of Physicians• Christine Bechtel National Partnership/Women & Families• Neil Calman Institute for Family Health• Tim Cromwell Department of Veterans Affairs• Art Davidson Denver Public Health• Marty Fattig Nemaha County Hospital• James Figge NY State Dept. of Health• Joe Francis Veterans Administration• Leslie Kelly Hall Healthwise• Yael Harris HRSA• David Lansky Pacific Business Group/Health• Deven McGraw Center/Democracy & Technology• Latanya Sweeney Carnegie Mellon University• Greg Pace Social Security Administration• Robert Tagalicod CMS/HHS• Karen Trudel CMS• Charlene Underwood Siemens• Amy Zimmerman Rhode Island Department of Health and Human Services

Page 3: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 3

HITPC Stage 3 MU Timeline

• Aug, 2012 – present draft preliminary stage 3 recs• Oct, 2012 – present pre-RFC preliminary stage 3 recs• Nov, 2012 – RFC distributed• Dec 21, 2012 – RFC deadline• Jan, 2013 – ONC synthesizes RFC comments for WGs review• Feb, 2013 – WGs reconcile RFC comments• Mar, 2013 – present revised draft stage 3 recs• Apr, 2013 – approve final stage 3 recs• May, 2013 – transmit final stage 3 recommendations to HHS

Page 4: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 4

Guiding PrinciplesMU Objectives

• Supports new model of care (e.g., team-based, outcomes-oriented, population management)• Addresses national health priorities (e.g., NQS, Million Hearts) • Broad applicability (since MU is a floor)

−Provider specialties (e.g., primary care, specialty care)−Patient health needs−Areas of the country

• Promotes advancement -- Not "topped out" or not already driven by market forces • Achievable -- mature standards widely adopted or could be widely

adopted by 2016• Add guideline about reasonableness (feasibility)

• Reapply principles to get to the next stage of objectives

Page 5: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations

Subgroup 1:Improve Quality Safety, Efficiency and

Reducing Health Disparities

5

Page 6: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 6

General Comment: Subgroup 1 & Overall• Which objectives address health disparities?

• Answer: Demographic collection & patient dashboard (with near real time results) provide the capability to record better demographic data and thus better reporting tools to help us focus our attention to populations that need it

• Is there more that can be done?• Have you explored objectives that would be helpful to organizations that are specifically addressing

health disparities and similar populations? • Answer: We have not focused on any specific organizations. We are interested in demographic

conditions and bettering our reporting• Has patient safety been explored within the institution setting? • Will there ever be 100% adherence to an objective?

• Answer: Setting the bar at 80% allows providers to maintain exclusions for why they do not have data on 100% of patients. There are legitimate reasons for omitted information and we do not want to penalize providers for those reasons. 80% is the highest we want to push as a policy initiative. We do not want to force providers to explain why they are missing some data for a few patients. We consider measures that are at 80% ‘topped out’ because if you are achieving 80% you have the capability to achieve 100%.

• Many items are not "e" ready. Are there ways to accelerate this work to share with the industry in an open source fashion. • Need to take advantage of HHS resources.

• Concern about timing, already behind for stage 2. • The stages should be driving each other, but we haven't had the time to learn from stage 1 which is

concerning. There are 4/5 things that could be identified that would dramatically improve things.• P&S as well interoperability and functions

Page 7: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP101

Objective: Use computerized provider order entry (CPOE) for medication, laboratory and radiology orders directly entered by any licensed healthcare professional who can enter orders into the medical record per State, local and professional guidelines to create the first record of the order.

Measure: More than 60% of medication, laboratory, and radiology orders created by the EP or authorized providers of the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) during the EHR reporting period are recorded using CPOE

Reconcile % after Stage 2 final

Objective: Use computerized provider order entry (CPOE) for medication, laboratory and radiology orders directly entered by any licensed healthcare professional who can enter orders into the medical record per State, local and professional guidelines to create the first record of the order.

Measure: More than 60% of medication, laboratory, and radiology orders created by the EP or authorized providers of the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) during the EHR reporting period are recorded using CPOE

No changes suggested.

SGRP130

New for stage 3 Objective: Use computerized provider order entry for referrals/transition of care orders directly entered by any licensed healthcare professional who can enter orders into the medical record per State, local and professional guidelines to create the first record of the order.

Measure: More than 20% of referrals/transition of care orders created by the EP or authorized providers of the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) during the EHR reporting period are recorded.

No changes suggested.

Improve Quality Safety, Efficiency and Reducing Health Disparities

7

Page 8: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 8

Improve Quality Safety, Efficiency and Reducing Health DisparitiesID Stage 2 NPRM Stage 3 Recommendations Stage 4

Placeholder HITPC Comments

SGRP102

Implement drug-drug and drug-allergy interaction checks

Consolidated with CDS

Consolidated with CDS

Certification: EHRs need to be able to consume external lists of DDIs (e.g., “never” combinations).

Seeking externally maintained list of DDIs with higher predictive value

No changes suggested.

SGRP103

EP Objective: Generate and transmit permissible prescriptions electronically (eRx)

EP Measure: More than 65 % of all permissible prescriptions written by the EP are compared to at least one drug formulary and transmitted electronically using Certified EHR Technology.

EH Objective: Generate and transmit permissible discharge prescriptions electronically (eRx)

EH Measure: More than 10% of hospital discharge medication orders for permissible prescriptions (for new or changed prescriptions) are compared to at least one drug formulary and transmitted electronically using Certified EHR Technology

EP Objective: Generate and transmit permissible prescriptions electronically (eRx)

EP Measure: More than 50% of all permissible prescriptions written by the EP are compared to at least one drug formulary (including generic substitutions) transmitted electronically using Certified EHR Technology.

EH Objective: Generate and transmit permissible discharge prescriptions electronically (eRx)

EH Measure: More than 30% of hospital discharge medication orders for permissible prescriptions (for new or changed prescriptions) are compared to at least one drug formulary and transmitted electronically using Certified EHR Technology

No changes suggested.

Page 9: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations

Improve Quality Safety, Efficiency and Reducing Health Disparities

9

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP104

Objective: Record the following demographics:• Preferred language• Gender• Race• Ethnicity• Date of birth

Measure: More than 80 percent of all unique patients seen by the EP or admitted to the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) have demographics recorded as structured data• (Hospital Only) date and preliminary cause of death in the event of mortality in the eligible hospital or CAH

Objective: Record the following in structured data:Demographics:• Preferred language• Gender• Race• Ethnicity• Date of birth• Occupation and industry codesClinical:• Sexual orientation, gender identity• Disability status

Measure: More than 80 percent of all unique patients seen by the EP or admitted to the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) have demographics recorded as structured data• (Hospital Only) date and preliminary cause of death in the event of mortality in the eligible hospital or CAH

No changes suggested.

Page 10: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

10

Improve Quality Safety, Efficiency and Reducing Health Disparities

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP105

Stage 1: Maintain an up-to-date problem list of current and active diagnoses for more than 80% of all unique patients: have at least one entry or an indication that no problems are known for patient recorded as structured dataStage 2: Consolidated with summary of care

New for stage 3Certification criteria only: EHR systems should provide functionality to help maintain up-to-date, accurate problem list

Stage 4: Patient input to reconciliation of problems

Clarify criteria - should provide the ability to write rules to ask the provider if something should on the problem list (doesn’t put on problem list). Capability within EHR to program this (not designated particular diseases).

How does a problem feed into diagnosis, orders, and care program?

SGRP106

Stage 1: Maintain active medication list: more than 80% of all unique patients have at least one entry recorded as structured data (or indication that the patient is on no meds) Stage 2: Consolidated with summary of care

New for stage 3Certification criteria only: EHR systems should provide functionality to help maintain up-to-date, accurate meds list

Auto-generated signals for med list?

SGRP107

Stage 1: Maintain active medication allergy list: More than 80% of all unique patients seen during the reporting period have at least one entry (or indication that the patient has no known medication allergies) recorded as structured dataStage 2: Consolidated with summary of care

New for stage 3Certification criteria only: EHR systems should provide functionality to code medication allergies and link to related drug family, and code related reaction.

Stage 4: Contraindications that could include: adverse reactions, procedural intolerance.

HITPC: MU Workgroup Stage 3 Recommendations

Page 11: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

11

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP108

Objective: Record and chart changes in vital signs:• Height/Length• Weight• Blood pressure (age 3 and over)• Calculate and display BMI• Plot and display growth charts for patients 0-20 years, including BMI

Measure: More than 80 percent of all unique patients seen by the EP or admitted to the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23), blood pressure (for patients age 3 and over only) and height/length and weight (for all ages) recoded as structured data

Maintain as is for Stage 3 or retire as topped out measure.

No changes suggested.

Note: 100% is always the goal, but from a policy perspective, 80% is the bar we want to set.

SGRP109

Objective: Record smoking status for patients13 years old or older

Measure: More than 80% of all unique patients 13 years old or older seen by the EP or admitted to the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) have smoking status recorded as structured data

Consider retiring or incorporating into CQM

No changes suggested.

Improve Quality Safety, Efficiency and Reducing Health Disparities

HITPC: MU Workgroup Stage 3 Recommendations

Page 12: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

12

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP110

Stage 1: Implement drug-formulary checks with access to at least one drug formularyStage 2: Consolidated - included within eRx core objective

Consolidated - Moved to eRx objective. No changes suggested.

SGRP111

Stage 1: Report ambulatory and hospital clinical quality measures to CMS or StatesStage 2: Removed, objective is incorporated directly into the definition of a meaningful EHR user and eliminated as an objective under 42 CFR 495.6

Removed No changes suggested.

SGRP112

EP: N/A

EH Objective: Record whether a patient 65 years old or older has an advance directive

EH Menu Measure: More than 50% of all unique patients 65 years old or older admitted to the eligible hospital's or CAH's inpatient department (POS 21) during the EHR reporting period have an indication of an advance directive status recorded as structured data.

Add for EPs if not included in Stage 2 and make core for EH.

Ensure standards support in CDA by 2016

Advanced directives hearing to further refine.

No changes suggested.

Improve Quality Safety, Efficiency and Reducing Health Disparities

HITPC: MU Workgroup Stage 3 Recommendations

Page 13: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 13

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP113

Objective: Use clinical decision support toimprove performance on high priorityhealth conditions

Measure: 1. Implement five clinical decision support interventions related to five or more clinical quality measures, if applicable, at a relevant point in patient care for the entire EHR reporting period.2. The EP, eligible hospital, or CAH has enabled the functionality for drug-drug and drug-allergy interaction checks for the entire EHR reporting period.

Objective: Use clinical decision support to improve performance on high priorityhealth conditionsMeasure: 1. Implement 15 clinical decision support interventions related to five or more clinical quality measures, if applicable, at a relevant point in patient care for the entire EHR reporting period. a. Include renal dosing checks (may need to be stage 4 due to lack of structured Sigs) b. Include CDS for appropriateness of lab or radiology orders (to avoid redundant or inappropriate orders)2. The EP, eligible hospital, or CAH has enabled the functionality for drug-drug and drug-allergy interaction checks for the entire EHR reporting period.

Certification criteria only:1. Ability to track CDS triggers and how the provider responded2. Ability to flag preference-sensitive conditions, and provide decision support materials for patients.

Lab/rad: How to determine the appropriate elements from this list? What are the basis of those determinations? Answer: ACR has guidelines for indications for repeat test, so there is the capability to program those into CDS: We intended this to serve as guidance only, it is still up to organization/provider as to how they apply the CDS. Intentions: 1 – EHR system should be able to write a rule;2- One of fifteen; start working on efficiency measures

Should this be included in a measure system for CQMs?

Can this objective and its processes be “e-ready” by 2016? Answer: This objective is about projecting to vendors where we plan to go so we keep them in the loop & they see where the product should be going.

Clarify the CDS trigger and “how provider responded” . Don't want this to be another work step.Note: We intend for this certification to require no extra work (a simple electronic response).

Improve Quality Safety, Efficiency and Reducing Health Disparities

Page 14: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations

Improve Quality Safety, Efficiency and Reducing Health Disparities

14

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP114

Objective: Incorporate clinical lab-test results into EHR as structured data

Measure: More than 55% of all clinical lab tests results ordered by the EP or by authorized providers of the eligible hospital or CAH for patients admitted to its inpatient or emergency department (POS 21 or 23) during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in Certified EHR Technology as structured data

Objective: Incorporate clinical lab-test results into EHR as structured data

Measure: More than 80% of all clinical lab tests results ordered by the EP or by authorized providers of the eligible hospital or CAH for patients admitted to its inpatient or emergency department (POS 21 or 23) during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in Certified EHR Technology as structured data

SGRP115

EP Objective: Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research, or outreach

EP Measure: Generate at least one report listing patients of the EP, eligible hospital or CAH with a specific condition.

EP Objective: Generate lists of patients for multiple specific conditions and present near real-time dashboards to use for quality improvement, reduction of disparities, research, or outreach

“Real-time” dashboards are extremely difficult. Change language to “near real-time dashboards” – still allows the dashboard to avoid being retrospective.

Provide more specificity around dashboards.

Need a measure: Report dashboard results longitudinally. Could be done by providers picking one or two disparity variables that make the most sense for population. Stratification of disparities in CQMs. Not putting demographics information to use.

Longitudinal measures in CQMs. Want to see in both sections.

Page 15: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 15

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP116

EP Objective: Use clinically relevant information to identify patients who should receive reminders for preventive/follow-up care

EP Measure: More than 10% of all unique patients who have had an office visit with the EP within the 24 months prior to the beginning of the EHR reporting period were sent a reminder, per patient preference

EP Objective: Use clinically relevant information to identify patients who should receive reminders for preventive/follow-up care

EP Measure: More than 20% of all unique patients who have had an office visit with the EP within the 24 months prior to the beginning of the EHR reporting period were sent a reminder, per patient preference

Exclusion: Specialists may be excluded for prevention reminders (could be more condition specific).

No changes suggested.

SGRP117

EH Objective: Automatically track medications from order to administration using assistive technologies in conjunction with an electronic medication administration record (eMAR)

Measure: More than 10% of medication orders created by authorized providers of the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) during the EHR reporting period are tracked using eMAR.

EH Objective: Automatically track medications from order to administration using assistive technologies in conjunction with an electronic medication administration record (eMAR)

Measure: 1) More than 10% of medication orders created by authorized providers of the eligible hospital's or CAH's inpatient or emergency department (POS 21 or 23) during the EHR reporting period are tracked using eMAR.2) Mismatches are tracked and acted upon (self-report policies and practices on handling reports of mismatches).

Re-write mismatches and self-report policies, this is confusing

Improve Quality Safety, Efficiency and Reducing Health Disparities

Page 16: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 16

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP118

Objective: Incorporate imaging results and information into Certified EHR Technology

Menu Measure: More than 40% of all scans and tests whose result is an image ordered by the EP or by an authorized provider of the eligible hospital or CAH for patients admitted to its inpatient or emergency department (POS 21 and 23) during the EHR reporting period are incorporated into or accessible through Certified EHR Technology

Move to core, pending Stage 2 Final Rule

No changes suggested.

SGRP119

Objective: Record patient family health historyas structured data

Menu Measure: More than 20% of all unique patients seen by the EP or admitted to the eligible hospital or CAH's inpatient or emergency department (POS 21 or 23) during the EHR reporting period have a structured data entry for one or more first-degree relatives or an indication that family health history has been reviewed

Objective: Record high priority family history data (including colon cancer, breast, glaucoma, MI, diabetes)

Measure: Record high priority family history in 40% of patients seen during reporting period

Certification criteria: Make sure that every CDS intervention can take into account family history for outreach (need to move that functionality along as part of preventative outreach).

No changes suggested.

Improve Quality Safety, Efficiency and Reducing Health Disparities

Page 17: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 17

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP120

Objective/Measure: Record electronic notes in patient records for more than 30 percent of office visits. While we believe that medical evaluation entries by providers are an important component of patient records that can provide information not otherwise captured within standardized fields, we believe there is evidence to suggest that electronic notes are already widely used by providers of Certified EHR Technology and therefore do not need to be included as a meaningful use objective.

Record electronic notes in patient records for more than 30% of office visits within four calendar days.

No changes suggested.

SGRP121

Hospital Objective: Provide structured electronic lab results to eligible professionals.

Hospital Measure: Hospital labs send (directly or indirectly) structured electronic clinical lab results to the ordering provider for more than 40 percent of electronic lab orders received.

Hospital Objective: Provide structured electronic lab results to eligible professionals.

Hospital Measure: Hospital labs send (directly or indirectly) structured electronic clinical lab results to the ordering provider for more than 70% of electronic lab orders received.

No changes suggested.

Objective Not Included in Stage 2 NPRM - Improve Quality Safety, Efficiency and Reducing Health Disparities

Page 18: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

18HITPC: MU Workgroup Stage 3 Recommendations 18

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP122

New for stage 3 EH: Explore Timely transition document (elements need to be fleshed out) that is available electronically within four calendar days for when a transition occurs between sites.

No changes suggested.

Improve Quality Safety, Efficiency and Reducing Health Disparities

Page 19: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 19

Subgroup 2: Engage Patients and Families

Page 20: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

20

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP204A

EP Objective: Provide patients the ability to view online, download, and transmit their health information within 4 business days of the information being available to the EP.EP Measure: 1. More than 50 percent of all unique patients seen by the EP during the EHR reporting period are provided timely (within 4 business days after the information is available to the EP) online access to their health information subject to the EP's discretion to withhold certain information2. More than 10 % of all unique patients seen by the EP during the EHR reporting period (or their authorized representatives) view, download , or transmit to a third party their health information

EH Objective: Provide patients the ability to view online and download information about a hospital admissionEH Measure: 1. More than 50 percent of all patients who are discharged from the inpatient or emergency department (POS 21 or 23) of an eligible hospital or CAH have their information available online within 36 hours of discharge 22. More than 10 percent of all patients who are discharged from the inpatient or emergency department (POS 21 or 23) of an eligible hospital or CAH view, download or transmit to a third party their information during the reporting period

Objective: Retain View/Download/Transmit

Explore further in RFC: Provide 50% of patients the ability to designate to whom and when (i.e. auto blue-button & on-demand) a summary of care document is sent to specific care team members (across settings/providers), and create ability of providers to review/accept updates.

Clarify - Blue button or the general concept? Ongoing update instead.

Clarify care team members - this is meant to be a cardiologist, radiologist, PCP, OBGYN, dentist, etc. and for each to be able to receive information. Assumes that those within the same practice are privy to same medical information.

How does this relate to the medical record?

HITPC: MU Workgroup Stage 3 Recommendations

Engage Patients and Families

Page 21: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 21

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP204B

New for Stage 3

Option 1: Provide 10% of patients with ability to submit information (provider chooses one or more of these information types according to what is most appropriate to their practice) such as:1. Family Health History [as per Surgeon General] 2. ODLs [as per How's Your Health ]3. Caregiver status and role [as per DECAF]4. Functional status [as per PROMIS 10]5. Patient-created health goals (needs a standard, also in care summary and plan)6. Medical device: Glucose level*7. Medical device: Blood Pressure*8. Medical device: Weight**[SNOMED/LOINC]

Option 2: Provide 10% of patients with ability to submit information using:1) A generic semi-structured questionnaire platform and 2) capability to receive uploads from home devices (e.g., glucometer, BP device, scale) that accommodate the data above.

Clarify provide (capability available, not demanding that it happen)

2) Consider: The cost to integrate information from devices is often the barrier.

Concern about the standards: Family Health History: Surgeon general standards are complex and may not be the best.

Engage Patients and Families

Page 22: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 22

Engage Patients and Families

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP204C

New for Stage 3Certification criteria only: Create capability to accept pre-visit prep tools into the EHR (e.g., the ability to consent to treatment, fill out administrative forms) (and also could send to other EHRs)

No changes suggested.

SGRP204D

New for Stage 3Objective: Offer 10% of patients the ability to update/correct information

No changes suggested.

Page 23: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

23

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP205

EP Objective: Provide clinical summaries for patients for each office visit

Measure: Clinical summaries provided to patients within 24 hours for more than 50 % of office visits.

Retain. May need to update content requirements after stage 2 FR

No changes suggested.

SGRP206

EP/EH Objective: Use Certified EHR Technology to identify patient-specific education resources and provide those resources to the patient

EP Measure: Patient-specific education resources identified by Certified EHR Technology are provided to patients for more than 10 percent of all office visits by the EP.

EH Measure: More than 10% of all unique patients admitted to the eligible hospital's or CAH's inpatient or emergency departments (POS 21 or 23) are provided patient- specific education resources identified by Certified EHR Technology

Retain objective

Add language support:Option 1: Of those patients who speak one of the top 5 nationally prevalent languages, 80% of materials must be provided in the language according to patient's preference, where materials are publicly available

Option 2: For one non-English speaking population, provide patient education materials in that language, where materials are publicly available

Certification requirement that delivers things in different languages. Most likely is someone who doesn't speak English within population. Option 1: 80% could be in English, reason for option 2.

Option 1 – Change language: “80% of patient-specific education materials”

Engage Patients and Families

HITPC: MU Workgroup Stage 3 Recommendations

Page 24: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 24

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP207

Objective: Use secure electronic messaging to communicate with patients on relevant health information

Measure: A secure message was sent using the electronic messaging function of Certified EHR Technology by more than 10 % of unique patients seen during the EHR reporting period

Measure: More than 15% of patients use secure electronic messaging to communicate with EPs

Stage 4: Create capacity for electronic episodes of care (telemetry devices, etc) and to do e-referrals and e-consults

No changes suggested.

SGRP208

EP Objective/Measure: Record patient preferences for communication medium for more than 20 % of all unique patients seen during the EHR reporting period. We believe that this requirement is better incorporated with other objectives that require patient communication and is not necessary as a standalone objective.

Retain, pending stage 2 FR No changes suggested.

Engage Patients and Families

Page 25: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 25

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP209

New for stage 3

Explore For Certification Rule Only: Capability for EHR to query research enrollment systems to identify available clinical trials.

No use requirements until Stage 4.

May want the capability to enter important enrollment criteria, rather than the EHR system going out and querying.Concern that we do not have the ability to do a certification rule.

Info button standard is there, but can we use it?This is signal to research community. This will allow a provider who has a patient that he/she wants to put into clinical trial to do so

SGRP210

Placeholder for Stage 4

Placeholder for Stage 4 Patients receive alerts for drug recalls, devices or other safety alerts; set preferences for receiving alerts.

Placeholder, but could be Stage 3. Have ability to generate lists and secure messaging in stage 2, then the ability will be there and won't need this objective - loop back after stage 2 final.

Objective not included - Engage Patients and Families

Page 26: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 26

Subgroup 3:Improve Care Coordination

Page 27: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 27

General Comments: Subgroup 3

•True care coordination depends upon exchanging data - long way from making it happen.

•Want a public hearing from people having trouble with this. • What are the issues?

•Remove percentages the are distracting and takes away from the policy that we are trying to accomplish.

•We need to figure out where the market is and where it will be in 2 years in order to understand the best infrastructure to transmit the data.

Page 28: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations28

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP301

Removed for an actual use case Eliminate for Stage 3 in favor of use cases.

N/A No changes suggested.

SGRP302

EP Objective: The EP who receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation.

EP Measure: The EP, eligible hospital or CAH performs medication reconciliation for more than 65% of transitions of care in which the patient is transitioned into the care of the EP or admitted to the eligible hospital’s or CAH’s inpatient or emergency department (POS 21 or 23)

EH Objective: The eligible hospital or CAH who receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation

EH Measure: The EP, eligible hospital or CAH performs medication reconciliation for more than 65% of transitions of care in which the patient is transitioned into the care of the EP or admitted to the eligible hospital’s or CAH’s inpatient or emergency department (POS 21 or 23)

EP / EH / CAH Objective: The EP, eligible hospital or CAH who receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform reconciliation for: - medications- medication allergies- problems

EP / EH / CAH Measure: The EP, EH, or CAH performs reconciliation for medications for more than 50% of transitions of care, and it performs reconciliation for medication allergies, and problems for more than10% of transitions of care in which the patient is transitioned into the care of the EP or admitted to the eligible hospital’s or CAH’s inpatient or emergency department (POS 21 or 23).

Reconciliation of contraindications (any medical reason for not performing a particular therapy; any condition, clinical symptom, or circumstance indicating that the use of an otherwise advisable intervention in some particular line of treatment is improper, undesirable, or inappropriate)

Is MU enough motivation for this measure? Yes.

Improve Care Coordination

Page 29: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 29

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP303

EP Objective: The EP who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary care record for each transition of care or referral.

EH Objective: The eligible hospital or CAH who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary care record for each transition of care or referral.

EP/EH /CAH Measure: 1. The EP, eligible hospital, or CAH that transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more than 65 % of transitions of care and referrals.2. The EP, eligible hospital, or CAH that transitions or refers their patient to another setting of care or provider of care electronically transmits a summary of care record using certified EHR technology to a recipient with no organizational affiliation and using a different Certified

EHR Technology vendor than the sender for more than 10 % of transitions of care and referrals.

EP/ EH / CAH Objective: EP/EH/CAH who transitions their patient to another setting of care or refers their patient to another provider of care - Provide a summary of care record for each site transition or referral when transition or referral occurs with available information

Measure: The EP, eligible hospital, or CAH that site transitions or refers their patient to another setting of care (including home) or provider of care provides a summary of care record for 65% of transitions of care and referrals (and at least 30% electronically).

Certification Criteria: EHR is able to set aside a concise narrative section in the summary of care document that allows the provider to prioritize clinically relevant information such as reason for transition and/or referral.

Must include the following four for transitions of site of care, and the first for referrals (with the others as clinically relevant): 1. Concise narrative in support of care transitions (free text that captures reason for referral or transition)2. Setting-specific goals3. Instructions for care during transition and for 48 hours afterwards4. Care team members, including primary care provider and caregiver name, role and contact info (using DECAF)

Where is the market going. Can we advance this in a different way?

Not identifying how this should be done. Is 30% threshold the appropriate way to drive exchange?

Judy Murphy - this is an area that we want to push.

Need optionality in terms of standards.

Improve Care Coordination

Page 30: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

30

ID Stage 2 NPRM Stage 3 Recommendations Stage 4

PlaceholderHITPC

Comments

SGRP304

New for Stage 3

EP/ EH / CAH Objective: EP/ EH/CAH who transitions their patient to another site of care or refers their patient to another provider of careFor each transition of site of care, provide the care plan information, including the following elements as applicable:•Medical diagnoses and stages •Functional status, including ADLs•Relevant social and financial information (free text)•Relevant environmental factors impacting patient’s health (free text)•Most likely course of illness or condition, in broad terms (free text)•Cross-setting care team member list, including the primary contact from each active provider setting, including primary care, relevant specialists, and caregiver•The patient’s long-term goal(s) for care, including time frame (not specific to setting) and initial steps toward meeting these goals•Specific advance care plan (POLST) and the care setting in which it was executed

For each referral, provide a care plan if one exists

Measure: The EP, eligible hospital, or CAH that transitions or refers their patient to another site of care or provider of care provides the electronic care plan information for 10% of transitions of care to receiving provider and patient/caregiver..

No changes suggested.

SGRP305

New for Stage 3

EP / EH / CAH Objective (new): EP/EH/CAH to whom a patient is referred acknowledges receipt of external information and provides referral results to the requesting provider, thereby closing the loop on information exchange.

Measure: For 10% of patients referred during an EHR reporting period, referral results generated from the EHR are returned to the requestor (e.g. via scan, printout, fax, electronic CDA Care Summary and Consult Report).

No changes suggested.

Improve Care Coordination

HITPC: MU Workgroup Stage 3 Recommendations

Page 31: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 31

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP127

Placeholder for Stage 4

Placeholder for Stage 4

Ability to maintain an up-to-date interdisciplinary problem list inclusive of versioning in support of collaborative care

No changes suggested.

SGRP125

Placeholder for Stage 4

Placeholder for Stage 4

Medication reconciliation: create ability to accept data feed from PBM (Retrieve external medication fill history for medication adherence monitoring)

No changes suggested.

Improve Care Coordination

Page 32: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 32

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP306

Objective/Measure: Record health care team members (including at a minimum PCP, if available) for more than 10 percent of all patients seen during the reporting period; this information can be unstructured. We believe that this requirement is better incorporated with other objectives that require summary of care documents and is not necessary as a standalone objective.

Added into care summary

No changes suggested.

SGRP307

Objective/Measure: Record care plan goals and patient instructions in the care plan for more than 10 percent of patients seen during the reporting period. We believe that this requirement is better incorporated with other objectives that require summary of care documents and is not necessary as a standalone objective.

Added into care summary

No changes suggested.

Objectives Not Included - Improve Care Coordination

Page 33: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 33

Subgroup 4: Improve Population and Public Health

Page 34: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 34

General comments: Subgroup 4

•(Judy F) – Does this objective keep in mind those who move from immunization system to another (I.e. moved from North Dakota to Utah). There is no national standard established – each state has different standards for how the data is stored, how it is formatted, how it is viewed/transferred There is an assumption that we are driving the market to come up with standards? HL7?

•But how do we drive the public health area (HIE in particular)? And how do we decide when to drive and when to follow the market?

•(Terry) – Again, it comes back to what is the state of readiness in the states? We don’t want to have unintended adverse consequence by putting out all this different stuff out there as objectives. Can we relook at this issue to drive capacity? •Have to consider the receiver of this information and the sender of this information in these objectives.

•Goal may be to drive states to adopt common standards.

Page 35: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 35

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP401A

Objective: Capability to submit electronic data to immunization registries or immunization information systems except where prohibited, and in accordance with applicable law and practice

Measure: Successful ongoing submission of electronic immunization data from Certified EHR Technology to an immunization registry or immunization information system for the entire EHR reporting period

EP/ EH Objective (New): Capability to receive a patient’s immunization history supplied by an immunization registry or immunization information system, and to enable healthcare professionals to use structured historical immunization events in the clinical workflow, except where prohibited, and in accordance with applicable law and practice.

Measure: Documentation of timely and successful electronic receipt by the Certified EHR Technology of vaccine history (including null results) from an immunization registry or immunization information system for 30% of patients who received immunizations from the EP/EH during the entire EHR reporting period.

Exclusion: EPs and EHs that administer no immunizations or jurisdictions where immunization registries/immunization information systems cannot provide electronic immunization histories.

Certification criteria: EHR is able to receive and present a standard set of structured, externally-generated, immunization history and capture the act and date of review within the EP/EH practice.

Stage 4 EP/EH Objective: Add submission of vaccine contraindication(s) and reason(s) for substance refusal to the current objective of successful ongoing immunization data submission to registry or immunization information systems.

Patients have the ability to access immunization records (assuming patients had access through v/d/t). Differentiate between EHR registry and public health.

Different rules between states in how data is collected. Driving the market to a common HL7 standard. Drive capacity at the state public health level - contributing to a database. Need public health department capacity.

Improve Population and Public Health

Page 36: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 36

Improve Population and Public Health

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP401B

New for Stage 3

EP/EH Objective (New): Capability to receive, generate or access appropriate age-, gender- and immunization history-based recommendations (including immunization events from immunization registries or immunization information systems) as applicable by local or state policy.

Measure: Implement an immunization recommendation system that: 1) establishes baseline recommendations (e.g., Advisory Committee on Immunization Practices), and 2) allows for local/state variations. For 20% of patients receiving an immunization, the EP/EH practice receives the recommendation before giving an immunization.

Exclusion: EPs and EHs that administer no immunizations.

Certification criteria: EHR uses a standard (e.g., national, state and/or local) rule set, plus patient age, gender, and prior immunization history to recommend administration of immunizations; capture the act and date/time of recommendation review.

No changes suggested.

Page 37: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 37

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP402A

EH Objective: Capability to submit electronic reportable laboratory results to public health agencies, except where prohibited, and in accordance with applicable law and practice

Measure: Successful ongoing submission of electronic reportable laboratory results from Certified EHR Technology to public health agencies for the entire EHR reporting period as authorized, and in accordance with applicable State law and practice.

EH Objective (unchanged): No change from current requirement for electronic lab reporting which generally is sent from the laboratory information system

No changes suggested.

Improve Population and Public Health

Page 38: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 38

Improve Population and Public Health

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP402B

New Objective presented for comment (Stage undetermined):EP Objective (new): Capability to use externally accessed or received knowledge (e.g. reporting criteria) to determine when a case report should be reported and then submit the initial report to a public health agency, except where prohibited, and in accordance with applicable law and practice.

Measure: Attestation of submission of standardized initial case reports to public health agencies on 20% of all reportable disease or conditions during the entire EHR reporting period as authorized, and in accordance with applicable state/local law and practice.

Certification criteria: The EHR uses external data to prompt the end-user when criteria are met for case reporting. The date and time of prompt is available for audit. Standardized (e.g., consolidated CDA) case reports are submitted to the state/local jurisdiction and the data/time of submission is available for audit

No changes suggested.

Page 39: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 39

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP403

Objective: Capability to submit electronic syndromic surveillance data to public health agencies and actual submission except where prohibited and in accordance with applicable law and practice

EH CORE Measure: Successful ongoing submission of electronic syndromic surveillance data from Certified EHR Technology to a public health agency for the entire EHR reporting period

Objective: Capability to submit electronic syndromic surveillance data to public health agencies and actual submission except where prohibited and in accordance with applicable law and practice

EP MENU Measure: Successful ongoing submission of electronic syndromic surveillance data from Certified EHR Technology to a public health agency for the entire EHR reporting period

No change from current requirements.

No changes suggested.

Improve Population and Public Health

Page 40: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 40

Improve Population and Public Health

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP404

EP Objective: Capability to identify and report cancer cases to a State cancer registry, except where prohibited, and in accordance with applicable law and practice.

EP Menu Measure: Successful ongoing submission of cancer case information from Certified EHR Technology to a cancer registry for the entire EHR reporting period

EH/EP Objective (New, pending Stage 2 Rule): Capability to electronically participate and send standardized, commonly formatted reports to a mandated jurisdictional registry (e.g., cancer, children with special needs, and/or early hearing detection and intervention) from Certified EHR to either local/state health departments, except where prohibited, and in accordance with applicable law and practice. This objective is in addition to prior requirements for submission to an immunization registry.

Measure: Documentation of ongoing successful electronic transmission of standardized reports from the Certified EHR Technology to the jurisdictional registry. Attestation of submission for at least 20% of all patients who meet registry inclusion criteria during the entire EHR reporting period as authorized, and in accordance with applicable State law and practice.

Certification criteria: EHR is able to build and then send a standardized report (e.g., standard message format) to an external mandated registry, maintain an audit of those reports, and track total number of reports sent.

Exclusion: where local or state health departments have no mandated registries or are incapable of receiving these standardized reports

Remiss to not try to embody public/patient health.

Certification only capabilities - hard to force states to do this if the states are not there.

Page 41: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

41

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP405

EP Objective: Capability to identify and report specific cases to a specialized registry (other than a cancer registry), except where prohibited, and in accordance with applicable law and practice.

EP Menu Measure: Successful ongoing submission of specific case information from Certified EHR Technology to a specialized registry for the entire EHR reporting period

Objective presented for comment (Stage undetermined):EP Objective (New, pending Stage 2 Rule): Capability to electronically submit standardized reports to an additional registry beyond any prior meaningful use requirements (e.g., immunizations, cancer, early hearing detection and intervention, and/or children with special needs). Registry examples include hypertension, diabetes, body mass index, devices, and/or other diagnoses/conditions) from the Certified EHR to a jurisdictional, professional or other aggregating resources (e.g., HIE, ACO), except where prohibited, and in accordance with applicable law and practice.

Measure: Documentation of successful ongoing electronic transmission of standardized (e.g., consolidated CDA) reports from the Certified EHR Technology to a jurisdictional, professional or other aggregating resource. Attestation of submission for at least 20% of all patients who meet registry inclusion criteria during the entire EHR reporting period as authorized, and in accordance with applicable state/local law and practice.

Certification criteria: EHR is able to build and send a standardized message report format to an external registry, maintain an audit of those reports, and track total number of reports sent.

Note: This objective is the same as the previous, but adds a second registry and does not need to be jurisdictional.

No changes suggested.

Improve Population and Public Health

HITPC: MU Workgroup Stage 3 Recommendations

Page 42: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 42

Improve Population and Public Health

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP407

New for Stage 3 EH Objective (new): Capability to electronically send standardized

Healthcare Associated Infection (HAI) reports to the National Healthcare Safety Network (NHSN) using a common format from the Certified EHR, except where prohibited, and in accordance with applicable law and practice.

Measure: Documentation of successful electronic transmission of standardized healthcare acquired infection reports to the NHSN from the Certified EHR Technology. Total numeric count of HAI in the hospital and attestation of Certified EHR electronic submission of at least 20% of all reports during the entire EHR reporting period as authorized, and in accordance with applicable State law and practice.

Certification criteria: EHR is able to sending a standard HAI message to NHSN, maintain an audit and track total number of reports sent.

No changes suggested.

Page 43: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 43

ID Stage 2 NPRM Stage 3 Recommendations Stage 4 Placeholder HITPC Comments

SGRP408

New Objective presented for comment (Stage undetermined):EH/EP Objective (new): Capability to electronically send adverse event reports (e.g., vaccines, devices, EHR, drugs or biologics) to the Federal Drug Administration (FDA) and/or Centers for Disease Control and Prevention (CDC) from the Certified EHR, except where prohibited, and in accordance with applicable law and practice.

Measure: Attestation of successful electronic transmission of standardized adverse event reports to the FDA/CDC from the Certified EHR Technology. Total numeric count (null is acceptable) of adverse event reports from the EH/EP submitted electronically during the entire EHR reporting period as authorized, and in accordance with applicable State law and practice.

Certification criteria: EHR is able to build and send a standardized adverse event report message to FDA/CDC and maintain an audit of those reports sent to track number of reports sent

Does this proposal mention anything about allowing access to patients & their significant others? There is a lot of demand for that kind of functionality (letting caregivers, sign. Others access immunization records and med records).

There are two different access registries: medical record (EHR) and public health registry (states) – need to consider thatWe cannot mediate the immunization registries through the EHR.

AHRQ comment: We need to keep in mind patient safety & immunization in this context

Improve Population and Public Health

Page 44: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 44

HITPC Final Comments

HearingsHIE

-Area in HIT riddled with problems-Need to hear problems and proposed/implemented solutions -Include P& S-Consider state-perspective (Gayle)-Consider specialists? (their records need interoperability as well)

Setting Direction

CDS -Essential to a learning health care system-Fear of CDS that tries to look at how providers respond to it [filter alerts CDS example]-Start directing decisions and limiting them, becomes a difficult path. Concern that payers and others are making decisions about how to limit care.

.

General•Requirements creep. Need core capabilities and an architecture that establishes it. •Concern about time, money, will power, and consensus to do all of this? •Are we in danger of diluting what we are trying to do with too many objectives.

•Stage 3 time to drive truly different care delivery. •Broad things that we need to focus on.

•MU has laid a tremendous foundation. We are seeing systems deployed by those who probably would not before MU. - There is a lack of evidence that we are achieving goals of MU & EHR. -We need to lay down clear tracks to lower costs and save lives. -Concerns about number of requirements

•Prioritizing: 56 objectives is too many

HITPC policy recommendationsImmunizations & other objectives that do not have the most mature standards: -HITPC considering making a policy statement regarding national standards for immunization data (so states can transmit immunization data)-The recommendation would join in with CDC (who has the authority to do this)

Page 45: HIT Policy Committee: Meaningful Use Workgroup Stage 3 – Preliminary Recommendations Debrief Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak,

HITPC: MU Workgroup Stage 3 Recommendations 45

Public CommentLarry Wolf Need to look carefully at the minimum necessary to achieve policy goals.

Darryl Roberts - P&S Tiger Team [nursing]LOA3 doesn't do what is intended - just by association. Interferes with patient care, takes away time and takes away from relationship with the patient. Committee did not discuss the use of biometrics. Thumb print reduces helpdesk calls too.

Julie Cantor-Weinberg [pathologist]A lot of pressure on labs. Pathologists are not included in objectives for stage 1 and 2, as they don't fit in. Urge the committee to revisit, as they are considered eligible providers. Move slowly on items related to lab data, need to make sure that the data can move in the appropriate format and can cause problems with patient safety.

Tom Larry - HIMSSGood dialogue around P&S. National HIT week September 14th.

Seth Foldy - wants the group to know that considerable work has been done with the lessons from stage 1 to find ways to tighten implementation and certification. Each of the implementation guides used in stage 1 have conformance statements. Working on harmonizing data elements across PH reports - stage 3 will have ramifications for future PH reporting.